1 / 34

The Liver in Sickle Cell Disease

The Liver in Sickle Cell Disease. Cage S. Johnson, M.D. Professor Emeritus of Medicine and of Physiology and Biophysics Director, Comprehensive Sickle Cell Center Keck School of Medicine, University of Southern California, Los Angeles, California, USA. HepatoBiliary Complications.

trudym
Download Presentation

The Liver in Sickle Cell Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Liver in Sickle Cell Disease Cage S. Johnson, M.D. Professor Emeritus of Medicine and of Physiology and Biophysics Director, Comprehensive Sickle Cell Center Keck School of Medicine, University of Southern California, Los Angeles, California, USA

  2. HepatoBiliary Complications • hemolysis & accelerated bilirubin catabolism • Transfusion therapy • Vaso-occlusion • Disorders unrelated to the hemoglobinopathy • SS> SC> S-thalassemias

  3. HepatoBiliary Complications: • Hepatomegaly • Hepatic ‘crisis’ (RUQ syndrome) • Hepatitis: viral, drug-induced, auto-immune • Hemosiderosis • Cholestasis: benign, progressive, drug-induced • Hepatic sequestration • Cirrhosis • Inspissated bile/Choledocholithiasis • Wide differential diagnosis

  4. Hepatomegaly • Increased blood volume and blood flow • Hepatocyte hyperplasia • Kupffer cell erythrophagocytosis, sinusoidal distention • Extra-medullary hematopoiesis • Passive congestion in right heart failure (pulmonary hypertension Haematologia 22:169, 1989 Serjeant, 2001 Am J Med 69:833, 1980 Dig Dis Sci 31:247, 1986 J Pediatr Hematol Oncol 24:125, 2002

  5. RUQ Syndrome • RUQ pain, leucocytosis • fever, nausea, vomiting • Jaundice: 3 to 12 mg/dL • Variable elevation of AP & ALT • Lasting 2 days to 3 weeks • Differentiate from cholecytitis Amer J Clin Pathol 44:1, 1965

  6. Cent Afr J Med 40:342, 1994 J Trop Pediatr 34:59, 1988

  7. Unusual causes of RUQ pain & abnl liver tests in Sickle Cell Disorders • Biloma • Focal nodular hyperplasia of the liver in children • Fungal ball • Hepatic artery stenosis • Hepatic infarct/abscess • Hepatic vein thrombosis • Mesenteric/colonic ischemia • Pancreatitis • Peri-colonic abscess • Pulmonary infarct/abscess • Renal vein thrombosis

  8. RUQ syndrome • Abdominal Examination • Ultrasound • Biliary scintigraphy: high false positive rate [fasting, hepatocellular disease, chronic cholecystitis, extra-hepatic obstruction, narcotic-induced spasm of the sphincter of Oddi] low positive predictive value but high negative predictive value-patent cystic duct

  9. Acute Viral Hepatitis N = 65: Hb SS - 6, Hb AS - 10, Hb AA (anemic) - 24, Hb AA - 25 • Peak bilirubin in Hb SS 4 x others; 40 mg/dL vs. 12 mg/dL • Hb SS 41 d vs. 25 to 38 d • AST, Alk P’tase, PT - no difference • Globulin persistently elevated in Hb SS • Degree of sickling on biopsy did not correlate with liver enzymes

  10. Hepatology 19:1513, 1994

  11. The Liver in Sickle Cell Disease Hb SS, n=100: 78 elev. Ind. Bili only Hb SC, n =25: 22 elev. Ind. Bili only Medicine (Balt) 64:349, 1985 Dig Dis Sci 31:247, 1986

  12. Auto-immune Hepatitis • Painless jaundice & marked poly-clonal gammopathy • Positive ANA, SMA, LKM-1 or SLA/LP • Histology shows dense T-cell peri-potal infiltrates • Extra hepatic manifestions: arthropahty, rash, leg ulcers • Rx: prednisone/azathiprine for 24 months Haematolgia 19:49, 1986 Am J Gastroenterol 91:1016, 1996 J Pediatr Hematol Oncol 19:159, 1997

  13. Chronic Liver Diseases Hb SS, n =22: Cirrhosis with hemosiderosis - 5, Cirrhosis without hemosiderosis, Chronic active hepatitis B - 2, Drug-induced cholestasis - 2, chronic passive chogestion, and 1 each with elev. Alkaline phosphatase - bone, common duct obstruction, Histiocytic lymphoma, sarcoidosis, benign cholestasis of pregnancy, acute viral hepatitis B and five unexplained. Hb SC, n = 3: 1 each with Alcoholic Liver Disease, granulomatous Hepatitis, unexplained. Medicine (Balt) 64:349, 1985 Dig Dis Sci 31:247, 1986

  14. Predictors of Liver disease

  15. Liver Histology Dig Dis Sci 31:247, 1986

  16. Hepatic Sequestration • Occurs about 1 per 161 admissions • Progressive enlargement of the liver with falling hemoglobin rising reticulocyte count • Markedly elevated bilirubin, predominantly conjugated fraction • Alkaline phosphatase as high as 650 IU • Modest elevation of transaminases [< 110 IU] • Obstruction of flow by vso-occlusion in small hepatic veins and/or sinusoids • Rx: exchange transfusion preferred BMJ 294:1206, 1987 BMJ 290:744 & 1214, 1985 Postgrad Med J 72:487, 1996

  17. Postgrad Med J 72:487, 1996

  18. Am J Hematol 42:81, 1993

  19. Br J Haematol 89:757, 1995

  20. Blood 96:76, 2000

  21. Blood 96:76, 2000

  22. Cirrhosis • Hepatitis B or C, auto-immune • Hemochromatosis • Chronic passive congestion • Miscellaneous: alcohol, toxins, sarcoidosis, cryptogenic, chronic biliary obstruction

  23. Summary • The majority of patients have only elevations of indirect bilirubin and LDH due to hemolysis • Chronic abnormalities in liver function are due to a wide variety of disorders other than the hemoglobinopathy. Judicious use of liver biopsy is often required for specific diagnosis. • Evidence for hepatitis B and C infection is common. Patients seropositive for hepatitis C have significantly greater serum globulin and transaminase levels than those seronegative.

  24. Summary • Kuppfer cell erythrophagocytosis and intrasinusoidal sickling are universally found in hepatic histology and are not related to the degree of transaminase elevation. The absence of shrunken hepatocytes speaks against the concept of anoxic liver damage and is more consistent with the liver as the site of RBC destruction in the absence of splenic function. • The increasing use of transfusion therapy in this patient population is associated with a high frequency of trnasfusion transmitted viral disease and iron overload; prudence dictates ongoing surveillance for these and other liver disorders that may affect these patients.

  25. Br Med J 295:234, 1987

  26. N Engl J Med 307:798, 1982

  27. J Pediatr 136:80, 2000

  28. Gastroenterology 112:463, 1997

More Related